Suchergebnisse - "SARS-CoV-2"

PubPharm (6.903)

1

Mechanistic study of the transmission pattern of the SARS-CoV-2 omicron variant

enthalten in: Proteins | 2024

von An, K. | Yang, X. | Luo, M. | +7

2

Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury in mice

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2024

von Sarnelli, G. | Del Re, A. | Palenca, I. | +9

3

Agonists or positive allosteric modulators of α7 nicotinic acetylcholine receptor prevent interaction of SARS-Cov-2 receptor-binding domain with astrocytoma cells

enthalten in: Biochemical and biophysical research communications | 2024

von Kalashnyk, O. | Lykhmus, O. | Sullivan, R. | +2

4

Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2

enthalten in: Annals of biomedical engineering | 2024

von O'Mahoney, C. | Watt, I. | Fiedler, S. | +6

5

A positive selection at binding site 501 in the B.1 lineage might have triggered the highly infectious sub-lineages of SARS-CoV-2

enthalten in: Gene | 2024

von Tiwary, B.

6

N-glycosylation of the SARS-CoV-2 spike protein at Asn331 and Asn343 is involved in spike-ACE2 binding, virus entry, and regulation of IL-6

enthalten in: Microbiology and immunology | 2024

von Das, T. | Luo, S. | Tang, H. | +15

7

Strategic development of a self-adjuvanting SARS-CoV-2 RBD vaccine : From adjuvant screening to enhanced immunogenicity with a modified TLR7 agonist

enthalten in: International immunopharmacology | 2024

von Meng, X. | Xu, Y. | Yang, J. | +4

8

Prevalence and diversity of imported severe acute respiratory syndrome coronavirus 2 variants in China, 2021-2022

enthalten in: Journal of medical virology | 2024

von Feng, Y. | Zhao, X. | Chen, Z. | +9

9

The human microbiota is a beneficial reservoir for SARS-CoV-2 mutations

enthalten in: mBio | 2024

von Cao, B. | Wang, X. | Yin, W. | +2

CommentIn: mBio. 2024 Apr 9;:e0053924. - PMID 38591881

10

Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor

enthalten in: mBio | 2024

von Cao, N. | Cai, Y. | Huang, X. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[691]